US OptionsDetailed Quotes
RIGL241220C22000
- 5.80
- 0.000.00%
15min DelayClose Dec 13 15:58 ET
0.00High0.00Low
5.80Open5.80Pre Close0 Volume1 Open Interest22.00Strike Price0.00Turnover815.59%IV47.01%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry5.80Extrinsic Value100Contract SizeAmericanOptions Type0.6164Delta0.0219Gamma3.26Leverage Ratio-0.7667Theta0.0007Rho2.01Eff Leverage0.0081Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet